GP100 ANTIGEN Uses, Dosage, Side Effects and more
GP100 ANTIGEN is under investigation in clinical trial NCT00006385 (Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma).
| Attribute | Details |
|---|---|
| Trade Name | GP100 ANTIGEN |
| Generic | GP-100 antigen |
| GP-100 antigen Other Names | GP100 ANTIGEN |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
